One Step at a Time: An Intervention to Reduce Sedentary Behavior Among Working Adults

Sponsor
University of Illinois at Urbana-Champaign (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05281978
Collaborator
(none)
76
2
12

Study Details

Study Description

Brief Summary

The proposed study will test the preliminary efficacy of a novel 12-week social cognitive theory-based intervention that will target reducing daily sitting time and increasing exercise participation among middle-aged working adults. This is a population highly susceptible to excessive sedentary time and low levels of exercise engagement. This two-arm randomized controlled trial (RCT) will examine the preliminary efficacy of decreasing sedentary time in addition to increasing moderate-vigorous intensity physical activity (MVPA) engagement, compared to a group which only receives MVPA promotion.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Decrease Sedentary Time + Increase MVPA group
  • Behavioral: Increase MVPA group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
76 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Health Services Research
Official Title:
One Step at a Time: Testing the Efficacy of a Novel Social Cognitive Theory-Based Intervention to Reduce Sedentary Behavior Among Working Adults
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Decrease Sedentary Time + Increase MVPA

Participants in this group will receive a 12-week, social cognitive theory-based intervention targetting reduction of daily sedentary time. This information will be delivered to them in the form of Zoom workshops, a program workbook, personalized step count goals, and a private social media page. The aim of this component will be to have participants displace their daily sedentary time with light-intensity physical activity, such as casual walking. The second component of this intervention will be increasing participants' weekly MVPA engagement. Participants will participate in 1 live, virtual aerobics-based exercise class per week and complete 2 additional sessions on their own time. Participants will build up to exercising 150 minutes/week (the federal physical activity recommendations).

Behavioral: Decrease Sedentary Time + Increase MVPA group
12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise; personalized step count goals to increase daily volume of physical activity and displacement of sedentary time

Active Comparator: Increase MVPA only

Participants in this group will only receive the MVPA-promoting component (which will be the same delivery as the intervention group). Participants in this arm will participate in 1 live, virtual aerobics-based exercise class per week (held separately from the intervention group) and will complete 2 additional exercise classes on their own time. Participants will build up to exercising 150 minutes/week (the federal physical activity recommendations).

Behavioral: Increase MVPA group
12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise

Outcome Measures

Primary Outcome Measures

  1. Changes in average daily step counts [Baseline,12 weeks]

    Participants will wear a hip-based pedometer for 7 days at baseline and 12 weeks

  2. Changes in average daily sedentary time [Baseline,12 weeks]

    Participants will wear a hip-based accelerometer for 7 days at baseline and 12 weeks to measure their daily time spent sedentary.

  3. Changes in average daily light-intensity physical activity [Baseline,12 weeks]

    Participants will wear a hip-based accelerometer for 7 days at baseline and 12 weeks to measure their daily time spent engaged in light-intensity physical activity.

  4. Changes in average daily moderate-vigorous intensity physical activity [Baseline, 12 weeks]

    Participants will wear a hip-based accelerometer for 7 days at baseline and 12 weeks to measure their daily time spent engaged in moderate-vigorous intensity physical activity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 45-65 years of age by study start date

  • Hold full-time employment (≥ 30 hours/week) at one or more jobs

  • Hold a sedentary-based job (which also allows for ability to freely move about during the workday)

  • Low active (engage in ≤2 days of 30+ minutes of structured moderate-vigorous intensity exercise/week)

  • Physician's consent to participate in aerobic testing and/or the exercise program (if needed based on Physical Activity Readiness Questionnaire responses)

  • Ambulatory

  • Absence of health conditions that may be made worse by exercise

  • Ability to complete all testing assessments in-person

  • Access to a laptop/desktop/phone with Zoom web-conferencing software

  • Fluent in English

Exclusion Criteria:
  • Under 45 or over 65 years of age

  • Not holding full-time employment (work < 30 hours/week at one or more jobs)

  • Hold a job(s) which is classified as light, medium, heavy, or very heavy work

  • Hold a sedentary-based job which does not allow for free movement throughout the workday (i.e., bus driver)

  • High active (engage in > 2 days or 30+ minutes of structured moderate-vigorous intensity exercise/week)

  • Non-consent of physician

  • Non-ambulatory (i.e., use of walkers, wheelchair, cane, etc.)

  • Presence of health conditions that may be made worse by exercise.

  • Unable to complete assessments in-person

  • No access to laptop/desktop/phone with Zoom software

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Illinois at Urbana-Champaign

Investigators

  • Principal Investigator: Neha P Gothe, MA, PhD, University of Illinois at Urbana-Champaign

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Illinois at Urbana-Champaign
ClinicalTrials.gov Identifier:
NCT05281978
Other Study ID Numbers:
  • 22651
First Posted:
Mar 16, 2022
Last Update Posted:
Mar 16, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 16, 2022